Patients With HVAD System At Risk, Warns FDA
The agency does not recommend elective removal of the device
The US Food and Drug Administration is advising health care providers that patients with the Medtronic Heartware Ventricular Assist Device (HVAD) System are at risk from potential device malfunction.
